
Biosynth發展歷程與介紹:
2019年Biosynth與Carbosynth合并成為Biosynth Carbosynth,致力于為全球客戶提供糖類核苷類和酶類產品。
2022年Biosynth集團收購了vivitide和Pepscan兩家公司,用以鞏固其多肽類產品業務及相關配套生產技術服務。 同年又收購了Aalto Bio Reagents公司以擴大其關鍵生物制劑業務,包括用于臨床診斷的抗原抗體產品線。同時集團也收購了EUCODIS Bioscience以鞏固其在酶技術領域的優勢。
2023年Biosynth集團收購美國Fitzgerald公司以及英國Cambridge Research Biochemicals公司,使其全球抗原抗體產品線擴大至57000+種,并進一步充實其多肽及抗體產品的相關服務能力。
貨號 | 品名 | 規格 | 品牌 |
PLP-3780-PI | Phe4,9 [Ring D5]-Hepcidin (Rat) | 0.1mg | biosynth |
STP-3621-PI-5mg | Ac-Phe-Thiaphe-OH | 5mg | biosynth |
EM35421 | 4-Methylumbelliferyl palmitate | 1g | biosynth |
EM15597 | 4-Methylumbelliferyl caprylate | 1g | biosynth |
crb1100420-0.4mg | Cathepsin G FRET substrate [5-FAM]/[6-TAMRA] | 0.4mg | biosynth |
crb1101508j | [5-FAM]/[Lys(Dabcyl)]-CoV Main Protease (Mpro) Substrate 1mg | 1mg | biosynth |
CRB2005004-20ug | Anti-Peroxiredoxin SO2/3 antibody | 20ug | biosynth |
OL01699 | Laminaritriose | 10mg | biosynth |
D-8823-5g | n-Dodecyl-beta-D-maltoside | 5g | biosynth |
EM01930-25mg | 4-Methylumbelliferyl a-L-fucopyranoside | 25mg | biosynth |
NM181126 | N2-Methylguanosine | 1mg | biosynth |
EM05134 | 4-Methylumbelliferyl b-D-galactopyranoside-6-sulphate sodium salt - Moscerdam biochemical purity | 25mg | biosynth |
NM08574 | N1-Methylguanosine | 5mg | biosynth |
ND05647 | N2,N2-Dimethylguanosine | 5mg | biosynth |
MA05068-1mg | D-Arabinose-5-phosphate disodium salt | 1mg | biosynth |
MD03540 | 2-Deoxy-2-fluoro-D-mannose | 25mg | biosynth |
MB32165-1g | Blue dextran (MW 2000000) - from Leuconostoc spp | 1g | biosynth |
FH29659 | trans-3-Hydroxy-L-proline | 50mg | biosynth |
H2N-IPAE(Cam)TTIYNR-OH | H2N-IPAE(Cam)TTIYNR-OH 11 residues >95% Purity Amino Acid Analysis (AAA) - No (Cam) = Cys-CAM (carbamidomethylation) | 50mgs | biosynth |
JZB56909 | Lalistat 2 | 2mg | biosynth |
電話
微信